全球干性老龄化相关黄斑部病变市场：趋势、预测与竞争分析（-2030）

预计2024年至2030年，全球干性老龄化黄斑部病变市场规模将以7.1%的复合年增长率成长。该市场的主要驱动因素是老年人口的增加和老龄化黄斑部病变盛行率的增加。全球干性老龄化黄斑部病变市场前景广阔，在医院和诊所、诊断中心以及学术和研究机构市场中蕴藏着未来性。

干性老龄化黄斑部病变市场洞察

Lucintel预测，由于老年人口的增加，75岁及以上的人口在预测期内将经历最大的增长。

在这个市场中，由于医院安装了先进和全面的治疗设施，医院和诊所将继续成为最大的细分市场。

由于政府倡议和财政支持进一步推动该地区的市场扩张，预计北美地区将在预测期内实现最高成长。

常问问题

Q1.市场成长预测如何？

A1. 预计 2024 年至 2030 年，全球干性老龄化黄斑部病变市场将以 7.1% 的复合年增长率成长。

Q2.影响市场成长的主要驱动因素有哪些？

A2. 此市场的主要驱动因素是老年人口的增加和老龄化黄斑部病变盛行率的增加。

Q3.市场的主要细分市场有哪些？

A3. 干性老龄化黄斑部病变市场在医院/诊所、诊断中心、学术/研究机构市场的未来性广阔。

Q4.市场上主要企业有哪些？

A4.干性老龄化黄斑部病变的主要企业如下。

• Santen Pharmaceuticals
• Allergan
• Bausch Health
• Alimera Science
• Phio Pharmaceuticals
• Ocumension Therapeutics
• Belite Bio
• Kubota Vision
• Iveric Bio
• Eyestem Research

Q5.未来最大的细分市场是什么？

A5.Lucintel预测，由于老年人口的增加，75岁及以上的人口在预测期内将经历最大的增长。

Q6. 未来五年预计哪个地区将成为最大的市场？

A6. 由于政府倡议和财政支持进一步促进该地区的市场扩张，预计北美地区将在预测期内呈现最高成长。

Q7. 可以客製化报告吗？

A7. 是的，Lucintel 提供 10% 的客製化服务，无需额外费用。

目录

第一章执行摘要

第二章全球干性老龄化黄斑部病变市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势与预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球干性老龄化黄斑部病变市场趋势（2018-2023）与预测（2024-2030）
• 全球干性老龄化黄斑部病变市场：依年龄组别
  • 75岁以上
  • 60岁以上
  • 40岁以上
• 全球干性老龄化黄斑部病变市场：依诊断及治疗分类
  • 治疗
  • 诊断
• 全球干性老龄化黄斑部病变市场：依给药途径
  • 口服
  • 注射
• 全球干性老龄化黄斑部病变市场：依最终用途产业
  • 医院/诊所
  • 诊断中心
  • 学术研究所
  • 其他的

第四章市场趋势与预测分析：按地区（2018-2030）

• 全球干性老龄化黄斑部病变市场：按地区
• 北美洲
• 欧洲
• 亚太地区
• 其他地区

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 按年龄组别
  • 透过诊断/治疗
  • 依给药途径
  • 按最终用途行业
  • 按地区
• 全球干性老龄化黄斑部病变市场的新兴趋势
• 战略分析
  • 新产品开发
  • 扩大全球干性老龄化黄斑部病变市场的产能
  • 全球干性老龄化黄斑部病变市场的合併、收购及合资企业
  • 认证和许可

第七章主要企业概况

• Santen Pharmaceuticals
• Allergan
• Bausch Health
• Alimera Science
• Phio Pharmaceuticals
• Ocumension Therapeutics
• Belite Bio
• Kubota Vision
• Iveric Bio
• Eyestem Research

Dry Age Related Macular Degeneration Trends and Forecast

The future of the global dry age related macular degeneration market looks promising with opportunities in the hospitals & clinics, diagnostic centers, and academic & research institutes markets. The global dry age related macular degeneration market is expected to grow with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are rising elderly populations and growing incidence of age-related macular degeneration.

A more than 150-page report is developed to help in your business decisions.

Dry Age Related Macular Degeneration by Segment

The study includes a forecast for the global dry age related macular degeneration by age group, diagnosis & treatment, route of administration, end use industry, and region.

Dry Age Related Macular Degeneration Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:

• Above 75 Years
• Above 60 Years
• Above 40 Years

Dry Age Related Macular Degeneration Market by Diagnosis & Treatment [Shipment Analysis by Value from 2018 to 2030]:

• Treatment
• Diagnosis

Dry Age Related Macular Degeneration Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

• Oral
• Injectables

Dry Age Related Macular Degeneration Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Diagnostic Centers
• Academic & Research Institutes
• Others

Dry Age Related Macular Degeneration Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Dry Age Related Macular Degeneration Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies dry age related macular degeneration companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the dry age related macular degeneration companies profiled in this report include-

• Santen Pharmaceuticals
• Allergan
• Bausch Health
• Alimera Science
• Phio Pharmaceuticals
• Ocumension Therapeutics
• Belite Bio
• Kubota Vision
• Iveric Bio
• Eyestem Research

Dry Age Related Macular Degeneration Market Insights

Lucintel forecasts that above 75 years is expected to witness largest growth over the forecast period due to rising population of senior patients.

Within this market, hospitals & clinics will remain the largest segment due to the installation of advanced and comprehensive treatment facilities in hospitals.

North America is expected to witness highest growth over the forecast period due to government initiatives and financial support are further driving the expansion of this market in this region.

Features of the Global Dry Age Related Macular Degeneration Market

Market Size Estimates: Dry age related macular degeneration market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Dry age related macular degeneration market size by various segments, such as by age group, diagnosis & treatment, route of administration, end use industry, and region in terms of value ($B).

Regional Analysis: Dry age related macular degeneration market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different age group, diagnosis & treatment, route of administration, end use industry, and regions for the dry age related macular degeneration market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the dry age related macular degeneration market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for dry age related macular degeneration market?

Answer: The global dry age related macular degeneration market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the dry age related macular degeneration market?

Answer: The major drivers for this market are rising elderly populations and growing incidence of age-related macular degeneration.

Q3. What are the major segments for dry age related macular degeneration market?

Answer: The future of the dry age related macular degeneration market looks promising with opportunities in the hospitals & clinics, diagnostic centers, and academic & research institutes markets.

Q4. Who are the key dry age related macular degeneration market companies?

Answer: Some of the key dry age related macular degeneration companies are as follows.

• Santen Pharmaceuticals
• Allergan
• Bausch Health
• Alimera Science
• Phio Pharmaceuticals
• Ocumension Therapeutics
• Belite Bio
• Kubota Vision
• Iveric Bio
• Eyestem Research

Q5. Which dry age related macular degeneration market segment will be the largest in future?

Answer: Lucintel forecasts that above 75 years is expected to witness largest growth over the forecast period due to rising population of senior patients.

Q6. In dry age related macular degeneration market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to government initiatives and financial support are further driving the expansion of this market in this region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the dry age related macular degeneration market by age group (above 75 years, above 60 years, and above 40 years), diagnosis & treatment (treatment and diagnosis), route of administration (oral and injectables), end use industry (hospitals & clinics, diagnostic centers, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Dry Age Related Macular Degeneration Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Dry Age Related Macular Degeneration Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Dry Age Related Macular Degeneration Market by Age Group
  • 3.3.1: Above 75 Years
  • 3.3.2: Above 60 Years
  • 3.3.3: Above 40 Years
• 3.4: Global Dry Age Related Macular Degeneration Market by Diagnosis & Treatment
  • 3.4.1: Treatment
  • 3.4.2: Diagnosis
• 3.5: Global Dry Age Related Macular Degeneration Market by Route of Administration
  • 3.5.1: Oral
  • 3.5.2: Injectables
• 3.6: Global Dry Age Related Macular Degeneration Market by End Use Industry
  • 3.6.1: Hospitals & Clinics
  • 3.6.2: Diagnostic Centers
  • 3.6.3: Academic & Research Institutes
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Dry Age Related Macular Degeneration Market by Region
• 4.2: North American Dry Age Related Macular Degeneration Market
  • 4.2.2: North American Dry Age Related Macular Degeneration Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
• 4.3: European Dry Age Related Macular Degeneration Market
  • 4.3.1: European Dry Age Related Macular Degeneration Market by Age Group: Above 75 Years, Above 60 Years, and Above 40 Years
  • 4.3.2: European Dry Age Related Macular Degeneration Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
• 4.4: APAC Dry Age Related Macular Degeneration Market
  • 4.4.1: APAC Dry Age Related Macular Degeneration Market by Age Group: Above 75 Years, Above 60 Years, and Above 40 Years
  • 4.4.2: APAC Dry Age Related Macular Degeneration Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
• 4.5: ROW Dry Age Related Macular Degeneration Market
  • 4.5.1: ROW Dry Age Related Macular Degeneration Market by Age Group: Above 75 Years, Above 60 Years, and Above 40 Years
  • 4.5.2: ROW Dry Age Related Macular Degeneration Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Dry Age Related Macular Degeneration Market by Age Group
  • 6.1.2: Growth Opportunities for the Global Dry Age Related Macular Degeneration Market by Diagnosis & Treatment
  • 6.1.3: Growth Opportunities for the Global Dry Age Related Macular Degeneration Market by Route of Administration
  • 6.1.4: Growth Opportunities for the Global Dry Age Related Macular Degeneration Market by End Use Industry
  • 6.1.5: Growth Opportunities for the Global Dry Age Related Macular Degeneration Market by Region
• 6.2: Emerging Trends in the Global Dry Age Related Macular Degeneration Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Dry Age Related Macular Degeneration Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Dry Age Related Macular Degeneration Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Santen Pharmaceuticals
• 7.2: Allergan
• 7.3: Bausch Health
• 7.4: Alimera Science
• 7.5: Phio Pharmaceuticals
• 7.6: Ocumension Therapeutics
• 7.7: Belite Bio
• 7.8: Kubota Vision
• 7.9: Iveric Bio
• 7.10: Eyestem Research